ALBIREO PHARMA, INC. Quarterly Income Tax Expense (Benefit) in USD from Q2 2010 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Albireo Pharma, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2010 to Q3 2022.
  • Albireo Pharma, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2022 was $0.000, a 100% decline year-over-year.
  • Albireo Pharma, Inc. annual Income Tax Expense (Benefit) for 2018 was $20K, a 90.6% decline from 2017.
  • Albireo Pharma, Inc. annual Income Tax Expense (Benefit) for 2017 was $212K, a 242% increase from 2016.
  • Albireo Pharma, Inc. annual Income Tax Expense (Benefit) for 2016 was $62K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $0 -$3.79K -100% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-08
Q3 2021 $3.79K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q1 2021 $0 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-06
Q1 2020 $0 $0 Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q3 2019 $20K $0 $0 Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $20K $0 $0 Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $20K $0 $0 Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $20K $20K -$192K -90.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-02
Q3 2018 $212K $0 $0 Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $212K $0 $0 Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $212K $0 $0 Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $212K $212K +$150K +242% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-06
Q3 2017 $62K $0 $0 Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $62K $0 $0 Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $62K $0 $0 Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $62K $62K +$54K +675% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-27
Q3 2016 $8K $0 Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 $0 -$20K -100% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-21
Q1 2016 $0 -$1K -100% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 $8K +$6K +300% Oct 1, 2015 Dec 31, 2015 10-Q 2016-02-16
Q2 2015 $26K $20K +$6K +42.9% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 $20K $1K -$3K -75% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $23K $2K -$3K -60% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-16
Q3 2014 $26K $3K -$9K -75% Jul 1, 2014 Sep 30, 2014 10-K 2015-12-22
Q2 2014 $35K $14K +$20K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 $15K $4K -$1K -20% Jan 1, 2014 Mar 31, 2014 10-Q/A 2015-06-01
Q4 2013 $16K $5K +$1K +25% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-12
Q3 2013 $15K $12K -$14K -53.8% Jul 1, 2013 Sep 30, 2013 10-K 2014-12-19
Q2 2013 $29K -$6K +$15K +71.4% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
Q1 2013 $14K $5K -$1K -16.7% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 $15K $4K -$3K -42.9% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-10
Q3 2012 $18K $26K +$17K +189% Jul 1, 2012 Sep 30, 2012 10-K 2013-12-20
Q2 2012 $1K -$21K -$47K -181% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 $48K $6K +$3K +100% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-13
Q4 2011 $45K $7K +$4K +133% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-14
Q3 2011 $41K $9K Jul 1, 2011 Sep 30, 2011 10-K 2013-12-20
Q2 2011 $26K +$64K Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-09-12
Q1 2011 $3K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q4 2010 $3K Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-09
Q2 2010 -$38K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.